Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
News & Media
  • Press Releases
  • Presentations
  • Events
  • Publications
  • Training Videos

Press Releases

Apr 4, 2017

Aethlon Medical Discloses Tech Nation Interview On National Public Radio

Mar 13, 2017

Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study

Mar 8, 2017

Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017

Mar 1, 2017

Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes

Feb 24, 2017

Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

Feb 22, 2017

Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies

Feb 10, 2017

Aethlon Medical Announces Fiscal 2017 Third Quarter Results

Feb 6, 2017

Aethlon Medical To Host Third Quarter Fiscal 2017 Investor Call On February 10, 2017

Jan 25, 2017

Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) in Former NFL Players

Jan 11, 2017

CEO Note - Clinical Study Update and a Review of 2016 Accomplishments

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.